Clinical Trials Directory

Trials / Completed

CompletedNCT07155330

High-flow Nasal Cannula Oxygenation in Sedated Endoscopy for High-risk Obstructive Sleep Apnea Patients

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
80 (actual)
Sponsor
Zhejiang University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Hypoxia is the most common adverse event during propofol sedation for gastrointestinal endoscopy. The STOP-BANG questionnaire is a widely used, simple assessment tool for screening obstructive sleep apnea (OSA) risk. A STOP-Bang score ≥5 indicates high-risk OSA patients who are more prone to hypoxia during sedated endoscopy. Our team's preliminary clinical research found that High-Flow Nasal Cannula (HFNC) may reduce hypoxemia risk, but there are limited dedicated studies focusing specifically on high-risk OSA patients, with controversial results. This study aims to investigate whether HFNC can reduce the incidence of hypoxia during sedated gastrointestinal endoscopy in high-risk obstructive sleep apnea patients.

Conditions

Interventions

TypeNameDescription
DEVICEHigh-flow nasal cannulaUsing high-flow nasal cannula oxygenation

Timeline

Start date
2025-09-05
Primary completion
2025-11-11
Completion
2025-11-11
First posted
2025-09-04
Last updated
2025-11-25

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT07155330. Inclusion in this directory is not an endorsement.